The use of low-dose cyclophosphamide followed by AZA/MMF treatment in childhood lupus nephritis

Pediatric Nephrology

Volumn 25, Issue 1, 2010, Pages 111-117

  Baskin, Esra ^a   Ozen, Seza ^b   Çakar, Nilgun ^c   Bayrakci, Umut S ^a   Demirkaya, Erkan ^d   Bakkaloglu, Aysin ^b  

^a BASKENT UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c MINISTRY OF HEALTH   (Turkey)

^d GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Children; Cyclophosphamide; Lupus nephritis; MMF; Treatment

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; DISEASE ACTIVITY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; DRUG PULSE THERAPY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEMORRHAGIC CYSTITIS; HUMAN; HUMAN TISSUE; INFECTION; KIDNEY FAILURE; LEUKOPENIA; LUPUS ERYTHEMATOSUS NEPHRITIS; MAINTENANCE THERAPY; MALE; MALIGNANT NEOPLASTIC DISEASE; NAUSEA; PRIORITY JOURNAL; REMISSION; SHORT COURSE THERAPY; TREATMENT RESPONSE;

ADOLESCENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS NEPHRITIS; MALE; MYCOPHENOLIC ACID; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 76749134044     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-009-1291-x     Document Type: Article

References (42)

1. P Niaudet 2000 Treatment of lupus nephritis in children Pediatr Nephrol 14 158 166 10.1007/s004670050034 1:STN:280:DC%2BD3c7kvVCisA%3D%3D 10684369
2. F Perfumo A Martini 2005 Lupus nephritis in children Lupus 14 83 88 10.1191/0961203305lu2065oa 1:STN:280:DC%2BD2M7gt1Sgug%3D%3D 15732294 (Pubitemid 40216074)
3. A Bakkaloglu 2001 Lupus nephropathy in children Nephrol Dial Transplant 16 Suppl 6 126 128 11568270
4. B Ranchin S Fargue 2007 New treatment strategies for proliferative lupus nephritis: keep children in mind Lupus 16 684 691 10.1177/0961203307079810 1:CAS:528:DC%2BD2sXht1amt7vF 17711908 (Pubitemid 47360008)
5. TJ Lehman K Onel 2000 Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus J Pediatr 136 243 247 10.1016/S0022-3476(00)70109-0 1:CAS:528:DC%2BD3cXhs1aqt7s%3D 10657833
6. S Vasoo GR Hughes 2005 Theory, targets and therapy in systemic lupus erythematosus Lupus 14 181 188 10.1191/0961203305lu2133oa 1:CAS:528: DC%2BD2MXjt12rs74%3D 15807193 (Pubitemid 40445580)
7. DT Felson J Anderson 1984 Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis. Results of a pooled analysis N Engl J Med 311 1528 1533 1:STN:280: DyaL2M%2FmtFeltg%3D%3D 6390198
8. RS Flanc MA Roberts GF Strippoli SJ Chadban PG Kerr RC Atkins 2004 Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials Am J Kidney Dis 43 197 208 10.1053/j.ajkd.2003.10. 012 1:CAS:528:DC%2BD2cXhsl2msL8%3D 14750085
9. HA Austin JH Klippel JE Balow NG le Riche AD Steinberg PH Plotz JL Decker 1986 Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs N Engl J Med 314 614 619 3511372
10. DT Boumpas HA Austin 3rd D Scott CH Yarboro EM Vaughan JH Klippel AD Steinberg CH Yarboro JE Balow 1992 Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis Lancet 340 741 745 10.1016/0140-6736(92)92292-N 1:STN:280:DyaK38vgvVentQ%3D%3D 1356175
11. MF Gourley HA Austin 3rd D Scott CH Yarboro EM Vaughan J Muir DT Boumpas JH Klippel JE Balow AD Steinberg 1996 Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis Ann Intern Med 125 549 557 1:CAS:528:DyaK28XmsFClsLs%3D 8815753
12. GG Illei HA Austin M Crane L Collinins MF Gourley CH Yarboro 2001 Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long term renal outcome without adding toxicity in patients with lupus nephritis Ann Intern Med 135 248 257 1:CAS:528:DC%2BD3MXms1WjtLc%3D 11511139
13. A Adams EJ MacDermott TJA Lehman 2006 Pharmacotherapy of lupus nephritis in children Drugs 66 1191 1207 10.2165/00003495-200666090-00003 1:CAS:528:DC%2BD28XotlKgs7w%3D 16827597 (Pubitemid 44050435)
14. FA Houssiau C Vasconcelos D D'Cruz GD Sebastiani ER Garrido MG Danieli D Abramovicz D Blockmans A Mathieu H Direskeneli M Galeazzi A Gul Y Levy P Petera R Popovic R Petrovic RA Sinico R Cattaneo J Font G Depresseux JP Cosyns R Cervera 2002 Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide Arthritis Rheum 46 2121 2131 10.1002/art.10461 1:CAS:528:DC%2BD38XmvFOqtbw%3D 12209517 (Pubitemid 34894769)
15. AC Allison 2005 Mechanisms of action of mycophenolate mofetil Lupus 14 s2 s8 10.1177/096120330501400102 1:CAS:528:DC%2BD2MXjtlaksr0%3D 15803924
16. TM Chan FK Li CSO Tang RWS Wong GX Fang YL Ji CS Lau AKM Wong MKL Tong KW Chan KN Lai 2000 Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis N Engl J Med 343 1156 1162 10.1056/ NEJM200010193431604 1:CAS:528:DC%2BD3cXnsleqs7w%3D 11036121 (Pubitemid 30781986)
17. EM Ginzler MA Dooley C Aranow MY Kim J Buyon JT Merrill M Petri GS Gilkeson DJ Wallace MH Weisman GB Appel 2005 Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis N Engl J Med 353 2219 2228 10.1056/NEJMoa043731 1:CAS:528:DC%2BD2MXht1GrsLbJ 16306519 (Pubitemid 41697285)
18. YF Fu GL Liu 2001 Mycophenolate mofetil therapy for children with lupus nephritis refractory to both intravenous cyclophosphamide and cyclosporine Clin Nephrol 55 318 321 1:CAS:528:DC%2BD3MXot1Smtb4%3D 11334319
19. S Buratti IS Szer CH Spencer S Bartosh A Reiff 2001 Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus J Rheumatol 28 2103 2108 1:CAS:528:DC%2BD3MXntVKnt70%3D 11550982
20. A Paredes 2007 Can mycophenolate mofetil substitute cyclophosphamide treatment of pediatric lupus nephritis? Pediatr Nephrol 22 1077 1082 10.1007/s00467-007-0463-9 17370094
21. JJ Weening VD D'Agati MM Schwartz SV Seshan CE Alpers GB Appel JE Balow JA Bruijn T Cook F Ferrario AB Fogo EM Ginzler L Hebert G Hill P Hill JC Jennette NC Kong P Lesavre M Lockshin LM Looi H Makino LA Moura M Nagata 2004 The classification of glomerulonephritis in systemic lupus ertythematosus revisited Kidney Int 65 521 530 10.1111/j.1523-1755.2004.00443.x 14717922 (Pubitemid 38130646)
22. C Bombardier DD Gladman MB Urowitz D Caron CH Chang 1992 Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE Arthritis Rheum 35 630 640 10.1002/art.1780350606 1:STN:280:DyaK383oslWrtg%3D%3D 1599520
23. SN Wong KC Tse TL Lee KW Lee S Chim KP Lee R Wai-Po Chu W Chan KW Fong J Hui S Po-Siu Li PS Yeung SF Yuen A Chi-Hang Ho L Chuk-Kwan Leung D Luk PC Tong SY Chan HM Cheung CM Chow D Lau 2006 Lupus nephritis in Chinese children- a territory-wide cohort study in Hong Kong Pediatr Nephrol 21 1104 1112 10.1007/s00467-006-0052-3 16639624 (Pubitemid 44083882)
24. R Bogdanovic V Nikolic S Pasic J Dimitrijevic J Lipkovska-Markovic J Eric-Marinkovic M Ognjanovic A Minic N Stajic 2004 Lupus nephritis in childhood: a review of 53 patients followed at a single center Pediatr Nephrol 19 36 44 10.1007/s00467-003-1278-y 14634858 (Pubitemid 38088248)
25. TJA Lehman K Onel 2000 Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus J Pediatr 136 243 247 10.1016/S0022-3476(00)70109-0 1:CAS:528:DC%2BD3cXhs1aqt7s%3D 10657833
26. S Emre I Bilge A Sirin I Kilicaslan A Nayir F Oktem V Uysal 2001 Lupus nephritis in children: prognostic significance of clinicopathological findings Nephron 87 118 126 10.1159/000045899 1:STN:280:DC%2BD3Mzgt1ajuw%3D%3D 11244305 (Pubitemid 32215822)
27. P Vachvanichsanong P Dissaneewate T Winn 2004 Intravenous cyclophosphamide for lupus nephritis in Thai children Scand J Rheumatol 33 339 342 10.1080/03009740410006448 1:CAS:528:DC%2BD2cXhtVajsbnF 15513684 (Pubitemid 39421219)
28. A Valeri J Radhakrishnan D Estes V D'Agati R Kopelman A Pernis R Flis C Pirani GB Appel 1994 Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five year study Clin Nephrol 42 71 78 1:STN:280:DyaK2M%2FktlKjtw%3D%3D 7955581
29. MP Dixit E Bracamonte N Dixit 2004 Intravenous cyclophosphamide-resistant systemic lupus erythematosus in Arizona Pediatr Nephrol 19 738 743 10.1007/s00467-004-1496-y 15141346 (Pubitemid 38931155)
30. JHM Beimler K Andrassy 2004 Cyclophosphamide treatment in systemic necrotizing vasculitis and lupus nephritis. How long? How much? Pediatr Nephrol 19 949 955 10.1007/s00467-004-1553-6 1:STN:280:DC%2BD2cvjt1OitQ%3D%3D 15257454 (Pubitemid 39242773)
31. HI Brunner A Bishnoi AC Barron LJ Houk A Ware Y Farhey AB Mongey CF Strife TB Graham MH Passo 2006 Disease outcomes and ovarian function of childhood onset systemic lupus erythematosus Lupus 15 198 206 10.1191/0961203306lu2291oa 1:STN:280:DC%2BD283mtF2gtg%3D%3D 16686258
32. DT Boumpas HA Austin 3rd EM Vaughan CH Yarboro JH Klippel JE Balow 1993 Risk of sustained amenorrhea in patients with SLE treated with intermittant pulse cyclophosphamide therapy Ann Intern Med 119 366 369 1:STN:280: DyaK3szjt1eitg%3D%3D 8338289
33. F Houssiau 2007 Thirty years of cyclophosphamide; assessing the evidence Lupus 16 212 216 1:CAS:528:DC%2BD2sXkvFymtb0%3D 17432109
34. FA Houssiau C Vasconcelos D D'Cruz GD Sebastiani E de Ramon Garrido MG Danieli D Abramovicz D Blockmans A Cauli H Direskeneli M Galeazzi A Gul Y Levy P Petera R Popovic R Petrovic RA Sinico R Cattaneo J Font G Depresseux JP Cosyns R Cervera 2009 The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose versus high-dose intravenous cyclophosphamide Ann Rheum Dis 10.1136/ard.2008.102533
35. S Fujinaga K Kaneko Y Ohtomo H Murakami M Takada S Akashi M Hira Y Yamashiro 2005 Induction therapy with low-dose intravenous cyclophosphamide, oral mizoribine, and steroids for severe lupus nephritis in children Pediatr Nephrol 20 1500 1503 10.1007/s00467-005-1983-9 16021476 (Pubitemid 41403433)
36. R Gutiérrez-Suárez N Ruperto R Gastaldi A Pistorio E Felici R Burgos-Vargas A Martini A Ravelli 2006 A proposal for a pediatric version of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index based on the analysis of 1,015 patients with juvenile-onset systemic lupus erythematosus Arthritis Rheum 54 2989 2996 10.1002/art.22048 16947634 (Pubitemid 44497780)
37. CC Mok KY Ying S Tang CY Leung KW Lee WL Ng RW Wong CS Lau 2004 Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis Arthritis Rheum 50 2559 2568 10.1002/art.20364 15334470 (Pubitemid 39062717)
38. S Hagelberg Y Lee J Bargman G Mah R Schneider C Laskin A Eddy D Gladman M Urowitz D Hebert E Silverman 2002 Long-term follow up of childhood lupus nephritis J Rheumatol 29 2635 2642 12465165
39. G Contreras V Pardo B Leclercq O Lenz E Tozman P O'Nan D Roth 2004 Sequential therapies for proliferative lupus nephritis N Engl J Med 350 971 980 10.1056/NEJMoa031855 1:CAS:528:DC%2BD2cXhvFGjsrc%3D 14999109 (Pubitemid 38269274)
40. S Fujinaga Y Ohtomo S Hara D Umino T Someya T Shimizu K Kaneko 2008 Maintenance therapy with mycophenolate mofetil for children with severe lupus nephritis after low-dose intravenous cyclophosphamide regimen Pediatr Nephrol 23 1877 1882 10.1007/s00467-008-0800-7 18414900
41. C Pecoraro G Malgieri M D'Armiento MM Balletta F Nuzzi M Caropreso 2005 Treatment of childhood lupus nephritis with mycophenolate mofetil: clinical and histopathological study J Am Soc Nephrol 16 557
42. EJ MacDermott A Adams TJA Lehman 2007 Systemic lupus erythematosus in children: current and emerging therapies Lupus 16 677 683 10.1177/ 0961203307079567 1:STN:280:DC%2BD2svpt12rug%3D%3D 17711907 (Pubitemid 47360007)